2017 News Releases

Webcast ImageWebcast
Initial Update: RA101495 Phase 2 Program in Paroxysmal Nocturnal Hemoglobinuria (PNH) (Live)
June 27, 2017 at 8:00 a.m. ET
Initial Update: RA101495 Phase 2 Program in Paroxysmal Nocturnal Hemoglobinuria (PNH)
June 27, 2017 8:00 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
Ra Pharmaceuticals to Host Conference Call on Initial Phase 2 Data for RA101495 in PNH

Read More

Ra Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference

Read More

Ra Pharmaceuticals to Present at the 22nd Congress of the European Hematology Association

Read More

Ra Pharmaceuticals to Present at the UBS 2017 Global Healthcare Conference

Read More

Ra Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals Initiates Dosing of RA101495 in PNH Patients

Read More

Ra Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update

Read More

Ra Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference

Read More

Ra Pharma Supports 10th Annual Rare Disease Day® and Joins Global Movement to Raise Awareness for Rare Diseases

Read More